| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kaoru Morikaw. [Analysis of drug safety information using large-scale adverse drug reactions database]. Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo hokoku = Bulletin of National Institute of Health Sciences. issue 129. 2012-02-16. PMID:22259840. |
antipsychotics caused adrs specific to each drug, and, in combination therapy, increased the incidences of diabetes mellitus, pancreatitis, and neuroleptic malignant syndrome; antiepileptics caused aes (adverse events) including serious skin reactions such as stevens-johnson syndrome (sjs), congenital anomaly, and closed-angle glaucoma; and antidepressants caused aes including serotonin syndrome, suicidal events, and congenital anomaly, and aes occurring at a higher incidence for other indications, drugs often used in the elderly and aes in combination therapy. |
2012-02-16 |
2023-08-12 |
Not clear |
| Abdulrazaq A H Sokoro, Joel Zivot, Robert E Arian. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. The Annals of pharmacotherapy. vol 45. issue 9. 2011-12-20. PMID:21878660. |
neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool. |
2011-12-20 |
2023-08-12 |
Not clear |
| Debbie Steele, Norman L Keltner, Teena M McGuines. Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome? Perspectives in psychiatric care. vol 47. issue 1. 2011-08-09. PMID:21418073. |
are neuroleptic malignant syndrome and serotonin syndrome the same syndrome? |
2011-08-09 |
2023-08-12 |
Not clear |
| Senaka Rajapakse, Lakshan Abeynaike, Thanushi Wickramarathn. Venlafaxine-associated serotonin syndrome causing severe rhabdomyolysis and acute renal failure in a patient with idiopathic Parkinson disease. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814334. |
the most likely diagnosis was serotonin syndrome induced by venlafaxine, although neuroleptic malignant syndrome was also considered. |
2011-08-08 |
2023-08-12 |
Not clear |
| Jonathan W Thompson, Angela C Johnso. Acute lithium intoxication: properly directing an index of suspicion. Southern medical journal. vol 104. issue 5. 2011-07-29. PMID:21606724. |
lithium toxicity, neuroleptic malignant syndrome, and the serotonin syndrome can present similarly and require rapid recognition. |
2011-07-29 |
2023-08-12 |
Not clear |
| Jeong-Min Kim, Soon-Tae Lee, Eun-Cheol Song, Keun-Hwa Jung, Dong-In Sinn, Hakjae Chung, Kon Chu, Manho Ki. Neurotoxic syndrome developed after taking sertraline and risperidone. Journal of clinical neurology (Seoul, Korea). vol 3. issue 3. 2011-07-14. PMID:19513287. |
neuroleptic malignant syndrome and serotonin syndrome share many common clinical features, and the term "neurotoxic syndrome" can be used when a clear distinction cannot be made between the two. |
2011-07-14 |
2023-08-12 |
Not clear |
| Jeong-Min Kim, Soon-Tae Lee, Eun-Cheol Song, Keun-Hwa Jung, Dong-In Sinn, Hakjae Chung, Kon Chu, Manho Ki. Neurotoxic syndrome developed after taking sertraline and risperidone. Journal of clinical neurology (Seoul, Korea). vol 3. issue 3. 2011-07-14. PMID:19513287. |
here we present a case of 19-year-old man who experienced serotonin syndrome caused by sertraline intake, and consecutive neuroleptic malignant syndrome by risperidone. |
2011-07-14 |
2023-08-12 |
Not clear |
| Bradley J Robottom, William J Weiner, Stewart A Facto. Movement disorders emergencies. Part 1: Hypokinetic disorders. Archives of neurology. vol 68. issue 5. 2011-07-04. PMID:21555633. |
in part 1, drug-induced syndromes including neuroleptic malignant syndrome, parkinsonism hyperpyrexia syndrome, and serotonin syndrome will be discussed. |
2011-07-04 |
2023-08-12 |
Not clear |
| Michele Fornar. Catatonia: a narrative review. Central nervous system agents in medicinal chemistry. vol 11. issue 1. 2011-06-17. PMID:21294706. |
what is clear is that neurotransmitters, such as dopamine (da), gamma-aminobutyric acid (gaba), and glutamate (glu), are of major importance in the pathogenesis of catatonia and neuroleptic malignant syndrome (nms) and that serotonin (5-hydroxytryptamine [5-ht]) is crucial to the development of serotonin syndrome (ss). |
2011-06-17 |
2023-08-12 |
Not clear |
| Mario Hensel, Klaus Böhler, Rudolf Marnitz, Christian Binder, Michael von Brever. [Intensive care treatment for neuroleptic malignant syndrome]. Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS. vol 45. issue 7-8. 2010-11-04. PMID:20665353. |
we report a case of severe neuroleptic malignant syndrome developing in a 28-year-old female patient following deliberate self-poisoning with atypical antipsychotic drugs and serotonin reuptake inhibitors. |
2010-11-04 |
2023-08-12 |
Not clear |
| Karen J McAllen, David R Schwart. Adverse drug reactions resulting in hyperthermia in the intensive care unit. Critical care medicine. vol 38. issue 6 Suppl. 2010-07-23. PMID:20502177. |
this review describes the pathophysiology of hyperthermia, as distinct from fever, and the physiology, diagnosis, and treatment of serotonin syndrome, neuroleptic malignant syndrome, malignant hyperthermia, and baclofen withdrawal. |
2010-07-23 |
2023-08-12 |
Not clear |
| Juan Carlos Gómez-Esteban, Joseba Barcena, Maribel Forcadas, Johanne Somme, Marta Agundez, Beatriz Tijero, Juan J Zarran. Neuroleptic malignant syndrome and serotonin syndrome in a female patient: a clinicopathologic case. Clinical neuropharmacology. vol 32. issue 5. 2010-06-01. PMID:19820435. |
neuroleptic malignant syndrome and serotonin syndrome in a female patient: a clinicopathologic case. |
2010-06-01 |
2023-08-12 |
Not clear |
| Juan Carlos Gómez-Esteban, Joseba Barcena, Maribel Forcadas, Johanne Somme, Marta Agundez, Beatriz Tijero, Juan J Zarran. Neuroleptic malignant syndrome and serotonin syndrome in a female patient: a clinicopathologic case. Clinical neuropharmacology. vol 32. issue 5. 2010-06-01. PMID:19820435. |
we report the case of a 24-year-old female patient who initially developed a neuroleptic malignant syndrome after haloperidol exposure and experienced 6 years later a serotonin syndrome after repeated fluoxetine exposure. |
2010-06-01 |
2023-08-12 |
Not clear |
| Maria L Salazar, Lea S Eilan. Intrathecal baclofen withdrawal resembling serotonin syndrome in an adolescent boy with cerebral palsy. Pediatric emergency care. vol 24. issue 10. 2009-04-14. PMID:19240673. |
intrathecal baclofen withdrawal should be differentiated with autonomic dysreflexia, malignant hyperthermia, neuroleptic malignant syndrome, and serotonin syndrome. |
2009-04-14 |
2023-08-12 |
Not clear |
| Yuji Odagak. Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics? Current drug safety. vol 4. issue 1. 2009-03-31. PMID:19149529. |
atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics? |
2009-03-31 |
2023-08-12 |
Not clear |
| N Jackson, J Doherty, S Coulte. Neuropsychiatric complications of commonly used palliative care drugs. Postgraduate medical journal. vol 84. issue 989. 2008-06-16. PMID:18372482. |
the syndromes or entities that will be considered are delirium, drug induced parkinsonism, akathisia, serotonin syndrome and neuroleptic malignant syndrome. |
2008-06-16 |
2023-08-12 |
Not clear |
| Koichi Nisijima, Katsutoshi Shioda, Tatsunori Iwamur. Neuroleptic malignant syndrome and serotonin syndrome. Progress in brain research. vol 162. 2008-04-07. PMID:17645916. |
neuroleptic malignant syndrome and serotonin syndrome. |
2008-04-07 |
2023-08-12 |
Not clear |
| Koichi Nisijima, Katsutoshi Shioda, Tatsunori Iwamur. Neuroleptic malignant syndrome and serotonin syndrome. Progress in brain research. vol 162. 2008-04-07. PMID:17645916. |
neuroleptic malignant syndrome (nms) develops during the use of neuroleptics, whereas serotonin syndrome is caused mainly by serotoninergic antidepressants. |
2008-04-07 |
2023-08-12 |
Not clear |
| Brendan T Carroll, Joseph W Y Lee, Kevin T Graham, Arthur Thalassinos, Christopher Thomas, Rob Kirkhar. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll Scale. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 20. issue 1. 2008-04-07. PMID:18297586. |
neuroleptic malignant syndrome (nms) shares common features with catatonia and serotonin syndrome (ss). |
2008-04-07 |
2023-08-12 |
Not clear |
| Ian J Bagule. The excitatory:inhibitory ratio model (EIR model): An integrative explanation of acute autonomic overactivity syndromes. Medical hypotheses. vol 70. issue 1. 2008-04-01. PMID:17583440. |
these syndromes include neuroleptic malignant syndrome, serotonin syndrome, dysautonomia (or paroxysmal sympathetic storms) following acquired brain injury, autonomic dysreflexia, parkinsonian-hyperpyrexia syndrome, malignant catatonia, intrathecal baclofen withdrawal, malignant hyperthermia, stiff man syndrome and irukandji syndrome. |
2008-04-01 |
2023-08-12 |
Not clear |